LEAVE NO THING BEHIND

Minimally Invasive Micro Sclerostomy is a Stentless, Simple & Fast Glaucoma treatment to effectively lower IOP without the need for invasive surgery.

A Minimal & Stent-less Treatment Innovation

MIMS is a rapid & minimal procedure at the forefront of Interventional Glaucoma treatments. Fewer post-op complications allows for effective IOP management.

How MIMS® Works

Minimally Invasive Micro Sclerostomy is fast, accessible & effective. It works by inserting a specially designed needle into the sclera & removing a small channel of tissue. This channel will remain open & contentiously drain, effectively reducing IOP.

A 'Ready-To-Use' Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to learn remotely, intuitive to operate & requires fewer staff to assist in non-surgical environments. A central control touchscreen sets the surgical parameters & a foot pedal initiates the precise handheld trefine needle movement.

Precision Opthalmic Treatment Technology

Novel Glaucoma treatment developed in Israel & practiced globally. Learn more about Sanoculis and MIMS® surgical device innovation.

Outstanding Clinical Performance

2:03±0:43

Min Procedure
duration

43%

IOP Reduction after 12
Months

85%

Medication reduction
at 12 mo.

ZERO

Major intra/post-op
complications

MIMS® Testimonials

News & Publications

Global Distribution & Partners

Israel

Israel

Germany

Italy

Switzerland

Holland & Belgium

France

Spain

Norway & Iceland

UK & Ireland

This site uses cookies to improve visitor experience & analyze web traffic. We may share usage data with analytics partners to enhance & optimize. By clicking accept, you consent to store on your device technologies described in our privacy policy & terms of use. Thank you. privacy policy & terms of use